Literature DB >> 24399365

Biochemical markers of bone turnover - uses and limitations.

Thinn Thinn Hlaing1, Juliet E Compston.   

Abstract

Bone turnover markers of resorption and formation are released during the process of bone remodelling. These markers have been extensively studied in a number of therapeutic trials of osteoporosis during the past decade. This has led to better understanding of their physiology, clinical applications and possible ways to optimize analytical techniques. Bone markers can complement the results of bone mineral density in the management of osteoporosis, but their use in clinical practice is challenged by pre-analytical and analytical variability. This review will discuss different types of bone markers, their limitations, use in different metabolic bone diseases and current recommendations from the International Osteoporosis Foundation and the International Federation of Clinical Chemistry and Laboratory Medicine bone marker standards working group.

Entities:  

Keywords:  Bone disorders; bone turnover markers; clinical studies

Mesh:

Substances:

Year:  2014        PMID: 24399365     DOI: 10.1177/0004563213515190

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  61 in total

1.  Safety and efficacy of denosumab in osteoporotic hemodialysed patients.

Authors:  Francescaromana Festuccia; Maryam Tayefeh Jafari; Alessandra Moioli; Claudia Fofi; Simona Barberi; Stefano Amendola; Salvatore Sciacchitano; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-07-09       Impact factor: 3.902

Review 2.  Bone remodeling markers and bone metastases: From cancer research to clinical implications.

Authors:  Arlindo Ferreira; Irina Alho; Sandra Casimiro; Luís Costa
Journal:  Bonekey Rep       Date:  2015-04-22

3.  The Effects of Indian Hedgehog Deletion on Mesenchyme Cells: Inducing Intermediate Cartilage Scaffold Ossification to Cause Growth Plate and Phalange Joint Absence, Short Limb, and Dwarfish Phenotypes.

Authors:  Jian Sun; Xiaochun Wei; Shengchun Li; Changqi Sun; Chunfang Wang; Pengcui Li; Dennis L Wei; Lei Wei
Journal:  Stem Cells Dev       Date:  2018-08-22       Impact factor: 3.272

Review 4.  Molecular and cellular basis of bone resorption.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2014-09-16

Review 5.  The association between critical illness and changes in bone turnover in adults: a systematic review.

Authors:  N Orford; C Cattigan; S L Brennan; M Kotowicz; J Pasco; D J Cooper
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

Review 6.  [Diagnostics in osteology].

Authors:  F Jakob; F Genest; L Seefried; E Tsourdi; C Lapa; L C Hofbauer
Journal:  Internist (Berl)       Date:  2016-07       Impact factor: 0.743

7.  Role of β-isomerized C-terminal telopeptides (β-CTx) and total procollagen type 1 amino-terminal propeptide (tP1NP) as osteosarcoma biomarkers.

Authors:  Tu Hu; Qingcheng Yang; Jing Xu; Zhichang Zhang; Nengbin He; Yuzhen Du
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 8.  The Utility of Biomarkers in Osteoporosis Management.

Authors:  Patrick Garnero
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

9.  Fermented Milk Products and Bone Health in Postmenopausal Women: A Systematic Review of Randomized Controlled Trials, Prospective Cohorts, and Case-Control Studies.

Authors:  Angel M Ong; Kai Kang; Hope A Weiler; Suzanne N Morin
Journal:  Adv Nutr       Date:  2020-03-01       Impact factor: 8.701

10.  Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).

Authors:  Debra L Barton; Lynne T Shuster; Travis Dockter; Pamela J Atherton; Jacqueline Thielen; Stephen N Birrell; Richa Sood; Patricia Griffin; Shelby A Terstriep; Bassam Mattar; Jacqueline M Lafky; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2017-11-21       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.